International. Biocoat Incorporated, a specialty manufacturer of hydrophilic biomaterial coatings for medical devices, announces that it has acquired Chempilots, a European provider of specialty polymers and production services to the medical device industry.
The transaction expands Biocoat's biomaterials platform offering in line with its strategy to enable medical innovation by providing a comprehensive portfolio of customized biomaterials solutions.
Joining Biocoat allows Chempilots to further advance its polymer development programs and provides access to additional markets.
In addition to supplying specialty polymers to current customers, Chempilots has a special focus on polymerization techniques to enable the development, scale-up and fabrication of biomaterials, such as hydrogels, for various medical device applications.
"We are thrilled to expand our biomaterials solutions platform by joining two companies that are built on long-term partnerships with their current and future customers," said Jim Moran, President and Chief Executive Officer of Biocoat.
"Both Biocoat and Chempilots supply medical device companies with unique chemical products and components to support their product development," Moran said.
"Both companies have built customer service models that have expert and dedicated staff focused on finding unique solutions to solve their customers' most challenging requirements."
Kim Sander Pedersen, CEO of Chempilots, noted, "We are excited to be part of a customer-focused team that is creating a unique solution for companies in need of specialized biomaterials solutions."
